Patients with arthritis undergoing surgery: How should we manage tumour necrosis factor blocking agents perioperatively?-A systematic literature review

Yonsei Medical Journal

Volumn 54, Issue 1, 2013, Pages 253-257

  Pieringer, Herwig ^a,b   Danninger, Kathrin ^a   Tzaribachev, Nikolay ^c   Böhler, Nikolaus ^a   Pohanka, Erich ^a,d   Herold, Manfred ^e  

^a KEPLER UNIVERSITY HOSPITAL   (Austria)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

^c Klinikum Bad Bramstedt   (Germany)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Arthritis; Infection; Surgery; Tumour necrosis factor blocking agents

Indexed keywords

ADALIMUMAB; CORTICOSTEROID; ETANERCEPT; INFLIXIMAB; METHOTREXATE; TUMOR NECROSIS FACTOR INHIBITOR; ANTIRHEUMATIC AGENT; CERTOLIZUMAB PEGOL; GOLIMUMAB; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; MACROGOL DERIVATIVE; MONOCLONAL ANTIBODY; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ARTHRITIS; HUMAN; INFECTION RISK; PERIOPERATIVE PERIOD; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SYSTEMATIC REVIEW; ANTAGONISTS AND INHIBITORS; INFECTION; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDY; RISK;

ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN G; INFECTION; PERIOPERATIVE PERIOD; POLYETHYLENE GLYCOLS; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; RECEPTORS, TUMOR NECROSIS FACTOR; RETROSPECTIVE STUDIES; RISK; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84871318525     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2013.54.1.253     Document Type: Review

References (20)

1. Listing J, Strangfeld A, Kary S, Rau R, von Hinueber U, Stoyanova-Scholz M, et al. Infections in patients with rheumatoid arthritis treated with biologic agents. Arthritis Rheum 2005;52:3403-12.
2. den Broeder AA, Creemers MC, Fransen J, de Jong E, de Rooij DJ, Wymenga A, et al. Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study. J Rheumatol 2007;34:689-95.
3. Pieringer H, Stuby U, Biesenbach G. Patients with rheumatoid arthritis undergoing surgery: how should we deal with antirheumatic treatment? Semin Arthritis Rheum 2007;36:278-86.
4. Bibbo C, Goldberg JW. Infectious and healing complications after elective orthopaedic foot and ankle surgery during tumor necrosis factor-alpha inhibition therapy. Foot Ankle Int 2004;25:331-5.
5. Giles JT, Bartlett SJ, Gelber AC, Nanda S, Fontaine K, Ruffing V, et al. Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis. Arthritis Rheum 2006;55:333-7.
6. Talwalkar SC, Grennan DM, Gray J, Johnson P, Hayton MJ. Tumour necrosis factor alpha antagonists and early postoperative complications in patients with inflammatory joint disease undergoing elective orthopaedic surgery. Ann Rheum Dis 2005;64:650-1.
7. Wendling D, Balblanc JC, Brousse A, Lohse A, Lehuede G, Garbuio P, et al. Surgery in patients receiving anti-tumour necrosis factor alpha treatment in rheumatoid arthritis: an observational study on 50 surgical procedures. Ann Rheum Dis 2005;64:1378-9.
8. Ruyssen-Witrand A, Gossec L, Salliot C, Luc M, Duclos M, Guignard S, et al. Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockers. Clin Exp Rheumatol 2007;25:430-6.
9. Corrao S, Pistone G, Arnone S, Calvo L, Scaglione R, Licata G. Surgery during etanercept therapy in patients with rheumatoid arthritis: is it time to follow patient preferences? Intern Emerg Med 2008;3:73-5.
10. Hirano Y, Kojima T, Kanayama Y, Shioura T, Hayashi M, Kida D, et al. Influences of anti-tumour necrosis factor agents on postoperative recovery in patients with rheumatoid arthritis. Clin Rheumatol 2010;29:495-500.
11. Kawakami K, Ikari K, Kawamura K, Tsukahara S, Iwamoto T, Yano K, et al. Complications and features after joint surgery in rheumatoid arthritis patients treated with tumour necrosis factor-alpha blockers: perioperative interruption of tumour necrosis factor-alpha blockers decreases complications? Rheumatology (Oxford) 2010;49:341-7.
12. Shergy WJ, Phillips RM, Hunt RE, Hernandez J. Infliximab and its impact on surgical outcomes in patients with rheumatoid arthritis. Ann Rheum Dis 2005;64(Suppl 3):1511.
13. Matthews JLK, Martin L, Hu R. Postoperative complications in rheumatoid arthritis patients on anti-TNF therapies undergoing orthopaedic procedures. Ann Rheum Dis 2006;65(Suppl 2):331.
14. Arkfeld DG, Kasraeian S, Metyas S, Itomura J. Use of anti-TNF agents in 15 rheumatoid arthritis patients undergoing total elbow arthroplasty. Ann Rheum Dis 2007;66(Suppl 2):534.
15. Dixon WG, Lunt M, Watson KD, Hyrich KL. Anti-TNF therapy and the risk of serious post-operative infection: results from the BSR biologics register (BSRBR). Ann Rheum Dis 2007;66(Suppl 2):118.
16. Kanbe K, Inoue K, Chiba J. Risk factors of infection after orthopaedic surgery with infliximab for rheumatoid arthritis. Ann Rheum Dis 2007;66(Suppl 2):174.
17. Ding T, Ledingham J, Luqmani R, Westlake S, Hyrich K, Lunt M, et al. BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies. Rheumatology (Oxford) 2010;49:2217-9.
18. Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008; 59:762-84.
19. Neufassung der Empfehlungen der Deutschen Gesellschaft für Rheumatologie zur Therapie mit Tumornekrosefaktor-hemmenden Wirkstoffen bei entzündlichrheumatischen Erkrankungen (Stand März 2006). http://dgrh.de/fileadmin/media/Praxis___Klinik/Therapie-Empfehlungen/TNF-Blocker_06.pdf.
20. Grennan DM, Gray J, Loudon J, Fear S. Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis 2001; 60:214-7.